Back to mobile site

Evofem Biosciences (EVFM) Reports Complete Phase 3 Clinical Trial of Amphora for Prevention of Pregnancy

November 8, 2018 6:51 AM EST Send to a Friend
Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced the last patient has completed her last visit in AMPOWER, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login